Administration of N-carbamylglutamate (NCG), an analogue of endogenous N-acetyl-glutamate (an activator of arginine synthesis) has been shown to enhance neonatal growth by increasing circulating arginine levels. However, the effect of NCG on pregnancy remains unknown. This study examined the effects of NCG on pregnancy outcome and evaluated potential mechanisms involved. Reproductive performance, embryo implantation, and concentration of amino acids in serum and uterine flushing, were determined in rats fed control or NCG supplemented diets. Ishikawa cells and JAR cells were used to examine the mechanism by which NCG affects embryo implantation. Dietary NCG supplementation increased serum levels of arginine, onithine, and proline, as well as uterine levels of arginine, glutamine, glutamate, and proline. Additionally, it stimulated LIF expression, and enhanced the activation of signal transduction and activator of transcription 3 (Stat3), protein kinase B (PKB), and 70-kDa ribosomal protein S6 kinase (S6K1) during the periimplantation period, resulting in an increase in litter size but not birth weight. In uterine Ishikawa cells, LIF expression was also enhanced by treatment with arginine and its metabolites. In trophoblast JAR cells, treatment with arginine and its metabolites enhanced Stat3, PKB, and S6K1 activation and facilitated cellular adhesion activity. These effects were abolished by pretreatment with inhibitors of phosphatidylinositol 3-kinase (wortmannin) and mammalian target of rapamycin (rapamycin). The results demonstrate that NCG supplementation enhances pregnancy outcome and have important implications for the pregnancy outcome of mammalian species.
References
[1]
Myrskyl？1 M, Kohler HP, Billari FC (2009) Advances in development reverse fertility declines. Nature 460: 741–743.
[2]
Benzies KM (2008) Advanced maternal age: are decisions about the timing of child-bearing a failure to understand the risks? Can Med Assoc J 178: 183–184.
[3]
emedicine.medscape website. Available: http://emedicine.medscape.com/article/26？0495-overview. Accessed 2012 Jun 24.
[4]
csrees.usda.gov website. Available: http://www.csrees.usda.gov/nea/animals/i？n_focus/reproduction_if_female.html. Accessed 2012 Jun 24.
[5]
Achache H, Revel A (2006) Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 12: 731–746.
[6]
Geisert RD, Schmitt RAM (2002) Early embryonic survival in the pig: can it be improved? J Anim Sci 80: E54–E65.
[7]
Goff AK (2002) Embryonic signals and survival. Reprod Domest Anim 37: 133–139.
[8]
Dey SK, Lim H, Das SK, Reese J, Paria BC, et al. (2004) Molecular cues to implantation. Endocr Rev 25: 341–373.
[9]
Stewart CL, Kaspar P, Brunet J, Bhatt H, Gadi I, et al. (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359: 76–79.
[10]
Schlafke S, Enders AC (1975) Cellular basis of interaction between trophoblast and uterus at implantation. Biol Reprod 12: 41–65.
[11]
Tapia A, Salamonsen LA, Manuelpillai U, Dimitriadis E (2008) Leukemia inhibitory factor promotes human first trimester extravillous trophoblast adhesion to extracellular matrix and secretion of tissue inhibitor of metalloproteinases-1 and -2. Hum Reprod 23: 1724–1732.
[12]
Teng CB, Diao HL, Ma XH, Xu LB, Yang ZM (2004) Differential expression and activation of Stat3 during mouse embryo implantation and decidualization. Mol Reprod Dev 69: 1–10.
[13]
Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, et al. (2010) Impacts of amino acid nutrition on pregnancy outcome in pigs: mechanisms and implications for swine production. J Anim Sci 88: E195–204.
[14]
Xiao XM, Li LP (2005) L-Arginine treatment for asymmetric fetal growth restriction. Int J Gynaecol Obstet 88: 15–18.
Mateo RD, Wu G, Bazer FW, Park JC, Shinzato I, et al. (2007) Dietary L-arginine supplementation enhances the reproductive performance of gilts. J Nutr 137: 652–656.
[17]
Bérard J, Bee G (2010) Effects of dietary L-arginine supplementation to gilts during early gestation on foetal survival, growth and myofiber formation. Animal 4: 1680–1687.
[18]
Zeng XF, Wang F, Fan X, Yang W, Zhou B, et al. (2008) Dietary arginine supplementation during early pregnancy enhances embryonic survival in rats. J Nutr 138: 1421–1425.
[19]
Wu G, Knabe DA, Kim SW (2004) Arginine nutrition in neonatal pigs. J Nutr 134: 2783S–2790S.
[20]
Bachman C, Colombo JP, Jaggi K (1982) N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observation and treatment. Adv Exp Med Biol 153: 313–319.
[21]
Schwahn BC, Pieterse L, Bisset WM, Galloway PG, Robinson PH (2010) Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia. Eur J Pediatr 169: 133–134.
[22]
Ucar SK, Coker M, Habif S, Saz EU, Karapinar B, et al. (2009) The first use of N-carbamylglutamate in a patient with decompensated maple syrup urine disease. Metab Brain Dis 24: 409–414.
[23]
Frank JW, Escobar J, Nguyen HV, Jobgen SC, Jobgen WS, et al. (2007) Oral N-carbamylglutamate supplementation increases protein synthesis in skeletal muscle of piglets. J Nutr 137: 315–319.
[24]
Wu X, Ruan Z, Gao Y, Yin Y, Zhou X, et al. (2010) Dietary supplementation with L-arginine or N-carbamylglutamate enhances intestinal growth and heat shock protein-70 expression in weanling pigs fed a corn- and soybean meal-based diet. Amino Acids 39: 831–839.
[25]
Wu G, Meininger CJ (2000) Arginine nutrition and cardiovascular function. J Nutr 130: 2626–2629.
[26]
O'Connor MF, Roizen MF (2001) Lactate versus chloride: which is better? Anesth Analg 93: 809–810.
[27]
Wu G, Bazer FW, Cudd TA, Jobgen WS, Kim SW, et al. (2007) Pharmacokinetics and safety of arginine supplementation in animals. J Nutr 137: S1673–S1680.
[28]
Lassala A, Bazer FW, Cudd TA, Li P, Li X, et al. (2009) Intravenous administration of L-citrulline to pregnant ewes is more effective than L-arginine for increasing arginine availability in the fetus. J Nutr 139: 660–665.
[29]
Meijer AJ, Lof C, Ramos IC, Verhoeven AJ (1985) Control of ureogenesis. Eur J Biochem 148: 189–196.
[30]
Guffon N, Vianey-Saban C, Bourgeois J, Rabier D, Colombo JP, et al. (1995) A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J Inherit Metab Dis 18: 61–65.
[31]
Grau E, Felipo V, Minana MD, Grisolia S (1992) Treatment of hyperammonemia with carbamoylglutamate. Hepatology 15: 446–448.
[32]
Hugentobler SA, Diskin MG, Leese HJ, Humpherson PG, Watson T, et al. (2007) Amino acids in oviduct and uterine fluid and blood plasma during the estrous cycle in the bovine. Mol Reprod Dev 74: 445–454.
[33]
Gao HJ, Wu G, Spencer TE, Johnson GA, Li X, et al. (2009) Select nutrients in theovine uterine lumen. I. amino acids, glucose, and ions in uterine lumenal flushings of cyclic and pregnant ewes. Biol Reprod 80: 86–93.
[34]
Van Winkle LJ (2001) Amino acid transport regulation and early embryo development. Biol Reprod 64: 1–12.
[35]
Wu G, Bazer FW, Davis TA, Kim SW, Li P, et al. (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37: 153–168.
[36]
Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE (2004) Maternal nutrition and fetal development. J Nutr 134: 2169–2172.
[37]
Martin PM, Sutherland AE, Van Winkle LJ (2003) Amino acid transport regulates blastocyst implantation. Biol Reprod 69: 1101–1108.
[38]
Petters RM, Johnson BH, Reed ML, Archibong AE (1990) Glucose, glutamine and inorganic phosphate in early development of the pig embryo in vitro. J Reprod Fertil 89: 269–75.
[39]
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489–492.
[40]
Dunglison GF, Barlow DH, Sargent IL (1996) Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 11: 191–196.
Mitchell MH, Swanson RJ, Oehninger S (2002) In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer. Biol Reprod 67: 460–464.
[44]
Nishida M (2002) The Ishikawa cells from birth to the present. Hum Cell 15: 104–117.
[45]
Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA (2010) Models for Study of Human Embryo Implantation: Choice of Cell Lines? Biol Reprod 82: 235–245.
[46]
Andersen CB, Roth RA, Conti M (1998) Protein kinase B/Akt induces resumption of meiosis in Xenopus oocytes. J Biol Chem 273: 18705–18708.
[47]
Kamei T, Jones SR, Chapman BM, McGonigle KL, Dai G, et al. (2002) The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells. Mol Endocrinol 16: 1469–1481.
[48]
Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, et al. (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278: 32124–32131.
[49]
Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Ratajczak CK, et al. (2005) The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev Biol 284: 377–386.
[50]
Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Moley KH (2006) Phosphatidylinositol 3-Kinase activity is critical for glucose metabolism and embryo survival in murine blastocysts. J Biol Chem 281: 6010–6019.
[51]
Rohde J, Heitman J, Maria EC (2001) The TOR kinases link nutrient sensing to cell growth. J Biol Chem 276: 9583–9586.
[52]
Gangloff YG, Dann SG, Svoboda P, Sticker M, Spetz JF, et al. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24: 9508–9516.
[53]
Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, et al. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710–6718.
[54]
Martin PM, Sutherland AE (2001) Exogenous amino acids regulate trophectoderm differentiation in the mouse blastocyst through an mTOR-dependent pathway. Dev
[55]
Chen XM, He J, Ding Y, Zeng L, Gao R, et al. (2009) The role of mTOR in mouse uterus during embryo implantation. Reproduction 138: 351–356.
[56]
Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, et al. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. P Natl Acad Sci USA 94: 3801–3804.
[57]
Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR (2003) Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 50: 316–321.
[58]
Yue ZP, Yang ZM, Wei P, Li SJ, Wang HB, et al. (2000) Leukemia Inhibitory Factor, Leukemia Inhibitory Factor Receptor, and Glycoprotein 130 in Rhesus Monkey Uterus During Menstrual Cycle and Early Pregnancy. Biol Reprod 63: 508–512.
[59]
Mitchell MH, Swanson RJ, Oehninger S (2002) In Vivo Effect of Leukemia Inhibitory Factor (LIF) and an Anti-LIF Polyclonal Antibody on Murine Embryo and Fetal Development Following Exposure at the Time of Transcervical Blastocyst Transfer. Biol Reprod 67: 460–464.
[60]
Lengyel F, Vértes Z, Kovács KA, K？rnyei JL, Sümegi B, et al. (2007) Effect of estrogen and inhibition of hosphatidylinositol-3 kinase on Akt and FOXO1 in rat uterus. Steroids 72: 422–428.
[61]
Xue Q, Nagy JA, Manseau EJ, Phung TL, Dvorak HF, et al. (2009) Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A164–Driven Angiogenesis, in Part by Blocking S6Kinase. Arterioscler Thromb Vasc Bio 29: 1172–1178.
[62]
Arnold JT, Kaufman DG, Sepp？l？ M, Lessey BA (2001) Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture cell model. Hum Reprod 16: 836–845.
[63]
Nishikawa T, Tomiya T, Ohtomo N, Inoue Y, Ikeda H, et al. (2007) Stimulation by glutamine and proline of HGF production in hepatic stellate cells. Biochem Bioph Res Co 363: 978–982.
